Abstracts - faqs.org

Abstracts

Business, international

Search abstracts:
Abstracts » Business, international

Bahamas success for Merlin

Article Abstract:

The Merlin Mk1 antisubmarine helicopter of the UK Royal Navy has completed almost 200 flight hours in six major tests of the aircraft's fighting capabilities that were conducted in the Bahamas. The trials, performed over a 30-day period with a flying rate of 60 hours for every aircraft, were able to achieve the navy's data-gathering goals in 72% of the projected flying hours. Eight Stingray trials were also successfully completed during the trials.

Publisher: Shephard Press
Publication Name: Defence Helicopter
Subject: Business, international
ISSN: 0963-116X
Year: 2000
Antisubmarine Helicopters, Bahamas

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


20/20 hindsight

Article Abstract:

The Russian Mi-24VM attack helicopter is the latest derivative of the Mi- 24VP Hind-E. Weighing 600 kg, the helicopter is lighter than the basic Mi- 24V Hind. The rotorcraft is powered by a new, more efficient rotor that produces an additional 300 kg of lift. Other features are the Mi-28 main and tail rotors and the non-standard unswept blade aerials above and below the tailboom.

Author: Gordon, Yefim
Publisher: Shephard Press
Publication Name: Defence Helicopter
Subject: Business, international
ISSN: 0963-116X
Year: 1999
Product information, Russia, Attack Helicopters

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Similar abstracts:
  • Abstracts: Spirit of the age. Medicinal light swords. The boom in depression
  • Abstracts: Thank you and goodbye. Races go to the Finnish
  • Abstracts: Saddle up. Competition at last. Why not Washington?
  • Abstracts: ELM Books: pas comme les autres. Stauffacher: Berne's English bookshop. English books in Basel
  • Abstracts: The state of US-Swiss affairs. Extending helping hands. New chip on the block
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.